FAM83B Activators
FAM83B Activators primarily function by influencing upstream signaling networks that FAM83B is involved in, such as the RAS-MAPK and PI3K-Akt pathways. Epidermal Growth Factor (EGF) and Epigallocatechin Gallate (EGCG) are examples of such activators, with EGF capable of initiating signaling cascades through its interaction with EGFR, and EGCG modulating EGFR activity. Sorafenib, an inhibitor of multiple kinases, can similarly alter downstream signaling and indirectly enhance FAM83B activity. Dihydrotestosterone (DHT) and Estradiol, by binding to their respective receptors, can initiate signaling cascades that involve FAM83B.
In the same vein, other FAM83B Activators like Cyclosporine A, Rapamycin, Forskolin, Staurosporine, H-89 dihydrochloride, GF109203X, and U0126 can influence FAM83B activity by modulating the function of critical signaling molecules. For instance, Cyclosporine A and Rapamycin, by inhibiting calcineurin and mTOR respectively, can alter downstream signaling, indirectly enhancing FAM83B activity. Similarly, Forskolin, by enhancing cAMPproduction, affects PKA activity and cellular signaling, leading to a upregulation of pathways that FAM83B is involved in. Staurosporine, H-89 dihydrochloride, GF109203X, and U0126 function as kinase inhibitors, altering signaling downstream.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits EGFR, leading to altered signaling downstream. Inhibition of EGFR can result in the upregulation of pathways that FAM83B is involved in, such as the RAS-MAPK pathway, indirectly enhancing FAM83B activity. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estradiol binds to estrogen receptors and initiates signaling cascades that may involve FAM83B, such as the PI3K-Akt pathway, thereby indirectly enhancing FAM83B activity. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib inhibits multiple kinases, altering signaling downstream. The altered signaling can lead to the upregulation of pathways that FAM83B is involved in, indirectly enhancing FAM83B activity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A inhibits calcineurin, leading to altered signaling downstream. Calcineurin inhibition can result in the upregulation of pathways that FAM83B is involved in, indirectly enhancing FAM83B activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, leading to altered signaling downstream. mTOR inhibition can result in the upregulation of pathways that FAM83B is involved in, indirectly enhancing FAM83B activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinases, altering signaling downstream. This altered signaling can lead to the upregulation of pathways that FAM83B is involved in, indirectly enhancing FAM83B activity. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 inhibits PKA, leading to altered signaling downstream. PKA inhibition can result in the upregulation of pathways that FAM83B is involved in, indirectly enhancing FAM83B activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X inhibits PKC, leading to altered signaling downstream. PKC inhibition can result in the upregulation of pathways that FAM83B is involved in, indirectly enhancing FAM83B activity. | ||||||